An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer. (linkinghub.elsevier.com)

Authors: Gu Y … Guan X Journal: Cell Reports Medicine Published: 2026-07-29 DOI: https://doi.org/10.1016/j.xcrm.2026.102948